Mr. Perez is a member of the board of directors at VIR. He was previously the president and CEO of Cubist Pharmaceuticals, Inc. From 2012 to 2014, he served as president and COO of Cubist, and from 2007 to 2012, as executive vice president and chief operating officer. He joined Cubist in 2003, as senior vice president of sales and marketing and led the launch of Cubicin® (daptomycin for injection).
Prior to joining Cubist, he served as vice president of Biogen, Inc.’s CNS Business Unit from 2001 to 2003, where he was responsible for commercial leadership of an $800 million neurology business unit, and from 1995 to 2001 he held positions of increasing responsibility within the commercial organization.
Mr. Perez serves on the board of directors of AMAG Pharmaceuticals (NASDAQ: AMAG), Cidara Therapeutics (NASDAQ: CDTX), Zafgen Inc. (NASDAQ:ZFGN) and Flex Pharma, Inc. (NASDAQ:FLKS). He is a member of the board of trustees of the Dana-Farber Cancer Institute, Inc., and the founder and chairman of Life Science Cares, Inc.
Mr. Perez received a B.S. in business from California State University, Los Angeles and an M.B.A. from the Anderson Graduate School of Management at the University of California, Los Angeles.